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ABSTRACT
The Split Ends (SPEN) protein was originally discov-
ered in Drosophila in the late 1990s. Since then, ho-
mologous proteins have been identified in eukaryotic
species ranging from plants to humans. Every family
member contains three predicted RNA recognition
motifs (RRMs) in the N-terminal region of the pro-
tein. We have determined the crystal structure of the
region of the human SPEN homolog that contains
these RRMs––the SMRT/HDAC1 Associated Repres-
sor Protein (SHARP), at 2.0 A˚ resolution. SHARP is
a co-regulator of the nuclear receptors. We demon-
strate that two of the three RRMs, namely RRM3 and
RRM4, interact via a highly conserved interface. Fur-
thermore, we show that the RRM3–RRM4 block is
the main platform mediating the stable association
with the H12–H13 substructure found in the steroid
receptor RNA activator (SRA), a long, non-coding
RNA previously shown to play a crucial role in nu-
clear receptor transcriptional regulation. We deter-
mine that SHARP association with SRA relies on
both single- and double-stranded RNA sequences.
The crystal structure of the SHARP–RRM fragment,
together with the associated RNA-binding studies,
extend the repertoire of nucleic acid binding prop-
erties of RRM domains suggesting a new hypothesis
for a better understanding of SPEN protein functions.
INTRODUCTION
The Split Ends (SPEN) gene was discovered in the mid-
1990s through genetic studies linked to homeotic pheno-
types in Drosophila (1,2). The severe developmental prob-
lems observed in knockout animals demonstrated its essen-
tial role (3,4). The rat homolog, called Msx2-Interacting
Nuclear Target (MINT), was later identified independently
in a screening for interacting homeoprotein during osteo-
genesis (5). MINT was shown to localize in the nucleus,
and, in vitro, its predicted RNA recognition motifs (RRMs)
were shown to interact with the osteocalcin (OC) prox-
imal promoter region as well as with several homopoly-
meric DNA sequences (5). MINT was also proposed as
a transcription repressor of the OC promoter. Multiple
SPEN/MINT protein functions have been systematically
reported as being associated with negative effects on tran-
scription (6–9). The capacity of SPEN proteins to recruit
transcriptional repressors was later shown to be due to
a conserved SPEN paralog and ortholog C-terminal do-
main (SPOC). This domain arbitrates the interaction with
the silencing mediator for retinoid and thyroid-hormone
repressor protein (SMRT/NCoR) as well as with the his-
tone deacetylase HDAC1 (10–13). The human homolog of
the SPENproteinwas renamed SMRT/HDAC1Associated
Repressor Protein or SHARP (we use this name through-
out the manuscript; 13). The structure of the SPOC domain
of SHARP has been previously determined, thus, provid-
ing important molecular details regarding the recruitment
of SMRT by the SPOC domain (10). SHARP has also a
proven role in Notch signalling, where SHARP and Notch-
1-IC seem to have an exclusive binding behaviour with their
partner RBP-J (12). The region responsible for the stable
recruitment of SHARP to RBP-J is located in the central
part of the protein, between residues 2804 and 2816 (12).
Simultaneously, several independent studies demonstrated
the role of SHARP in nuclear receptor-mediated transcrip-
tional responses (13–15). The three predicted RRMs in
the N-terminal region of SHARP were shown to mediate
its negative transcriptional activity in the nuclear recep-
tor pathway, both in vitro and in vivo (13,15). These effects
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were shown to occur via its association with the non-coding
RNA produced by the steroid receptor activator gene (SRA
RNA; 13,15). A particular region containing the H12–H13
substructure of SRARNAwas shown to be sufficient tome-
diate SHARP association (15). RRMs are the most abun-
dant RNA-binding domains (RBDs) present in vertebrates
(they have been found in 0.5%–1% of human genes; 16).
Interestingly, biochemical and structural studies of RRMs
have generally shown that every RRMplays its own specific
role in cellular functions; this is in spite of their structural
similarities (17,18).
We have determined the crystal structure of the three
RRMs present in the N-terminal part of SHARP. The
atomic model revealed domain architecture where RRM3
and RRM4 form a platform, with RRM2 being linked flex-
ibly. The residues responsible for the interaction between
RRM3 and RRM4 are highly conserved throughout the
SPEN family. Moreover, while the RRM3 has the consen-
sus amino acids for single-stranded RNA association, the
RNA-binding surface of RRM4 is blocked by an -helix
located immediately downstream of the RRM fold––a situ-
ation reminiscent of the newly defined xRRMpresent in the
LARP protein (19). The xRRMs have the atypical proper-
ties of binding base-paired RNA sequences. We then char-
acterized the association of the RRMs of SHARP with the
H12–H13 RNA. Point mutations in the RRM3 or deletion
of the RRM4 strongly destabilize the interaction with the
H12-H13 fragment. The RRM3/RRM4 platform is there-
fore crucial for the formation of a stable complex with the
H12–H13 region of the SRA RNA. We suggest that the as-
sociation of SHARP with the H12–H13 RNA sequence is
specific and requires stable stem loops including base-paired
sequences. Our structural and biochemical data highlight
the unexpected properties of the SHARP RRMs, which
bring a new layer of complexity in the RNA recognition
mode of proteins containing multiple RRMs.
MATERIALS AND METHODS
Molecular Biology
The nucleotide sequence encoding residues 335 to 620 of
the human SHARP was obtained by gene synthesis (En-
telechon) and named R2–3–4h. The sequence was codon-
optimized for protein expression in Escherichia coli (E. coli)
and it was then subcloned in a pET-based vector contain-
ing N-terminal 9XHistidine and Glutathione S-Transferase
tags followed by the Tobacco Etch Virus (TEV) protease
cleavage site. The truncation of SHARP–RRMcorrespond-
ing to the constructs R3 (residues 436–512), R2–3 (residues
336 to 513), and R3–4h (residues 436 to 620) were cloned
in the same expression plasmid and produce using the same
protocol. The point mutants (R3mut and R2mut-R3mut)
were obtained by site-directed mutagenesis of the plasmid
encoding R2–3–4h using a Quick-Change mutagenesis kit
(Stratagene) according to the manufacturer’s instructions.
The R3mut construct contains the following mutations:
F441A, K470A, Y478A, F480A, and K512A. The R2mut-
R3mut construct contains the same mutations plus K338A,
Q369A,H371A, E376A, L380A, andF382A.All constructs
were verified using DNA sequencing prior to large-scale ex-
Table 1. Data collection and refinement statistics
Data collection
Space group P212121
Cell dimensions
a, b, c (A˚) 60.9, 69.8, 89.1
α, β, γ (◦) 90, 90, 90
Resolution (A˚) 50.0–2.0 (2.05–2.00)
Rmeas (%) 5.1 (106.6)
CC1/2 (%) 99.9 (72.8)
I/σ I 20.44 (2.21)
Completeness (%) 99.7 (100.0)
Redundancy 5.4 (5.6)
Refinement
Resolution (A˚) 28.7–2.00
Number of reflections 26035
Rwork /Rfree (%) 19.24/23.77
Number of atoms
Protein 2325
Solvent 161
B-factors
Protein 44.7
Solvent 45.1
Root mean square deviations
Bond length (A˚) 0.008
Bond angle (◦) 1.096
Ramachandran plot (%)
Favored region 97.9
Allowed region 2.1
Outliers region 0
pression. Primer sequences used for the truncations or the
mutations are provided in Supplementary Table S1. nullnull
Protein expression and purification
All the proteins tested in the subsequent experiments were
produced using the same protocol. Briefly, large cultures
of E. coli BL21 Star cells, previously transformed with a
given SHARP construct, were grown in Terrific Broth me-
dia (1.2% peptone, 2.4% yeast extract, 72 mM K2HPO4,
17 mM KH2PO4, and 0.4% glycerol) at 37◦C for 4 h. This
was followed by overnight induction at 18◦C with 0.25
mM isopropyl--D-thiogalactopyranoside. Cells were har-
vested using centrifugation at 5200 rcf and resuspended
in 50 mM HEPES buffer (pH 7.5) containing 300 mM
NaCl, 20 mM imidazole, 0.1% X-Triton 100, DNase 1 (1
g/ml), Lysozyme (1 g/ml), 5 mM -mercaptoethanol,
and a cocktail of protease inhibitors (PhenylMethylSulfonyl
Fluoride 1mM, leupeptin 1g/ml, and pepstatin 2g/ml).
Cells were lysed using an Emulsiflex system (Avestin) and
cleared using centrifugation at 33,000 rcf for 30 min at
4◦C. The soluble fraction was subjected to an initial affin-
ity purification using a chelating HiTrap FF crude column
(GE Healthcare) charged with Ni2+ ions. The protein was
eluted with 250 mM imidazole and desalted against 50 mM
HEPES (pH 7.5), 300 mM NaCl, 20 mM imidazole, and 5
mM -mercaptoethanol. The TEV protease was added at
a ratio of 1/50 (TEV/protein), and the sample was incu-
bated at 4◦C for 3 h. The cleaved protein was separated from
the tags, the protease, and the contaminants by a second
affinity purification on a chelatingHiTrap FF crude column
charged with Ni2+ ions. The flow-through was collected and
directly loaded on aHeparin column (GEHealthcare) to re-
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move the remaining contaminants. Elution was performed
with a linear salt gradient between 0.05 and 1 M of NaCl.
The fractions containing the elution peak were analysed on
a SDS-PAGE and pooled. The protein was further cleaned
using gel filtration chromatography with a Superdex 75 col-
umn (GE Healthcare) in 20 mM HEPES (pH 7.5) contain-
ing 150 mM NaCl, 1 mM -mercaptoethanol, 5% (v/v)
glycerol, and 5 mM MgCl2. The protein eluted from the
gel filtration column as monomers and was concentrated
(MWCO 30 KDa; Amicon) to 10 mg/ml. The concentrated
protein was used immediately for crystallization or stored
at −80◦C. All protein samples were more than 95% pure as
judged by Coomassie-stained SDS-PAGE gels.
Crystallization
The SHARP construct, encompassing residues 335 to 620,
was crystallized at a concentration of 10 mg/ml (0.3 mM)
using the sitting-drop vapour diffusion technique at 4◦C,
mixing an equal volume of the protein and the reservoir
solution. Initial screening with nanolitre volumes of drops
gave one crystal in one condition (Natrix screen, Hampton
research); this was further optimized to obtain diffraction
quality crystals. Final crystals were grown from a mixture
of 0.5 l of protein with 0.5 l of mother liquor (0.1 M am-
monium sulphate, 0.01Mmagnesium chloride hexahydrate,
0.05M MES monohydrate pH 5.6, and 16% w/v polyethy-
lene glycol 8000). Prior to flash freezing in liquid nitrogen,
crystals were put into perfluoropolyether CryoOil (Hamp-
ton Research).
Data collection, structure determination, and refinement
Diffraction data were collected at the European Syn-
chrotron Radiation Facility (ESRF, Grenoble) and pro-
cessed using XDS (20). Data collection statistics are shown
in Table 1. The structure of R2–3–4h was determined
by molecular replacement using the PHASER programme
from the CCP4 package (21).We used three ensembles, each
one containing several RRM structures as models: Ensem-
ble 1 (PDB codes: 3MD1, 2ADC, 2DNM, 2DGU, 2CQB),
Ensemble 2 (PDB codes: X4AR, 2YTC, 4F26, 1WHY,
2CPZ), and Ensemble 3 (PDB codes: 2I38, 1WHY, 1×55,
2LCW, 2CPE). Because the quality of the original densities
was not good enough to allow reconstruction of our protein
model, we performed several cycles of density modification
using the SOLOMON programme (22); this gave a read-
ily interpretable electron density map. The final model was
built using the COOT molecular graphics programme (23)
and refined using routine phenix.refine from the PHENIX
programme (24). We included TLS refinement using the
following groups: group1, amino acids 335–411; group 2,
amino acids 412–429; group 3, amino acids 430–513; group
4, amino acids 514–588; and group 5, amino acids 589–620
(25). The coordinates and the structure factors have been
deposited in the PDB with accession code 4P6Q.
Electrophoretic mobility shift assay (EMSA)
Radiolabelled RNAs were synthesized in vitro using the T7
RNA polymerase (home made) in the presence of 32P-
UTP. The transcription reactions were performed as pre-
viously described (26). We used various DNA templates to
produce the RNA sequences used in our EMSA. The pu-
rified and radiolabelled RNAs (0.1 pmol) were incubated
with increasing concentrations of the different SHARP con-
structs for 20 min at room temperature in 20 mM HEPES
(pH 7.5) containing 150 mM NaCl, 5 mM MgCl2, and
0.5 U of Superase (Invitrogen). Samples were then mixed
with native loading dye (50% glycerol, 0.2% bromophenol,
and 0.2% xylene cyanol) and loaded on a 5% native poly-
acrylamide gel. Gels were run in standard 1X Tris-borate–
EDTA buffer at 200 V for 2 h at 4◦C and visualized using
autoradiography.
For the competition assays, the cold RNAs correspond-
ing to the H12–H13, H12, H13, and H7 sequences were
synthesized in vitro using T7 RNA polymerase as indicated
above. Purified RNAs were annealed at low concentration
by heating them at 90◦C for 5 min followed by a slow reduc-
tion of temperature to 30◦C over an extra hour, and were
subsequently kept on ice. The short single-stranded RNAs
LA, LB, LC, UL, and USL were ordered (Thermo Scien-
tific, Dharmacon), deprotected and resuspended in water
before annealing as recommended by the manufacturers.
TheR2–3–4h/H12-H13 complexwas prepared as described
above. We then added the cold RNAs at different concen-
trations and incubated them for an additional 10 min. The
samples were subsequently analysed on a 5% native gel as
previously.
RESULTS
Structure of the SHARP–RRM fragment
The SHARP protein has three RRMs located in its N-
terminal region. The same protein fragment has previously
been shown to bind to and modulate the transcriptional
activity induced by the SRA RNA (13). We determined
the atomic structure of the protein construct encompass-
ing residues 335 to 620 (SHARP–RRM or R2–3–4h) at a
resolution of 2.0 A˚. The model contains the three predicted
RBDs plus two helices at the C-terminus (Figure 1A and B;
see statistics in Table 1). The crystal structure revealed that
the predicted RBDs fold into three individual RRMs with
the typical  topology. These RBDs were named
RRM2, RRM3, and RRM4 as the N-terminal region of
SHARP was predicted to have an additional RRM (en-
compassing residues 6 to 81). The SHARP protein frag-
ment is organized in two blocks, made of the RRM2 on
one hand and the RRM3-RRM4 on the other. A flexible
linker connects these two blocks (Figure 1B). Furthermore,
the C-terminal tail folds into two consecutive -helices im-
mediately after the RRM4 (Figure 1C and D). The first of
these two helices interacts extensively with the RRM4 -
sheet surface, thereby covering the putative RNA-binding
surface of this RRM (Figure 1C and D). The presence of a
helical extension immediately following the predictedRBDs
has been observedmultiple times in other RRM-containing
proteins (27–29). In a few cases, specific functions have been
attributed to these C-terminal helices. For instance, the C-
terminal helix C in the U1A protein is shown to reorient
upon RNA association (30,31), and the helical extension
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Figure 1. Overall structure of SHARP–RRMs. (A) Schematic representation of the domain organization of the SHARP protein. (B) The overall structure
of R2–3–4h is shown: RRM2 is coloured in yellow, RRM3 in orange, RRM4 in red, C-terminal helices in grey, and linker regions are coloured in green.
(C) and (D) Top (C) and side (D) views of the RRM4 plus the C-terminal -helix. The protein is shown as a cartoon and coloured in red for the RRM
and grey for the helix. (E) Superposition of various RRMs followed by C-terminal helices. The xRRM found in the p65 protein is coloured in green (PDB
code 4EYT). The qRRM 1 and 2 from the hnRNP F in complex with the AGGGAU hexa-ribonucleotide are coloured in gold and magenta, respectively.
The nucleotides are colored according to atom types (carbon: yellow; nitrogen: blue; oxygen: red; and phosphate: orange). SHARP is coloured in red with
the helix coloured in grey. Proteins are shown as a cartoon and residues involved in intramolecular interactions in panels C and D are shown as sticks and
coloured according to atom type (carbon: cyan; nitrogen: blue; and oxygen: red).
6746 Nucleic Acids Research, 2014, Vol. 42, No. 10
found in the splicing factor protein p14 is responsible for
the tight association with the splicing factor SF3b155 (27).
The hnRNP F protein contains three copies of the qRRM
domains which have their -sheet surfaces partially covered
by a C-terminal helix (32). It was further shown that qR-
RMs bind their RNA target using the loop regions rather
than -sheet surface (29). Another example is found in the
recently described xRRM present in the p65 protein (19).
This atypical type of RRM is present in members of the La
protein family and is known to interact with specific sites
of the telomerase RNA (33). The C-terminal helix found
in the xRRM makes it capable of establishing a combi-
nation of single- and double-strand-mediated interactions
with its RNA target (19). Structural superimposition of
SHARP RRM4 including the C-terminal helix onto indi-
vidual RRM domains from the hnRNP F or the p65 pro-
teins clearly shows the conserved location of the additional
secondary structure element found in the SHARP protein
(Figure 1E). With the notable exception of U1A, every the
RRMs that are followed by a C-terminal helix are unable
to bind RNA through the -sheet surface, suggesting that
RRM4 could follow this trend (Figure 1D and E).
Comparison of the predicted domain organization of an-
notated SPEN protein family members, ranging frommam-
malian to plant species, underlines the conserved organi-
zation of the N-terminal region within this family (Sup-
plementary Figure S1). This conserved region can be di-
vided in twomodules: one which contains anRRM (RRM2
in SHARP) and a second module containing two RRMs
(RRM3 and RRM4 in SHARP). These two blocks are con-
nected through a relatively long linker of ∼20–30 amino
acids (Supplementary Figure S1). Interestingly, the plant
proteins belonging to the SPEN family have an atypical
primary sequence organization. In these species, the RRM
corresponding to the human RRM2 is located after the
RRM3/RRM4 block (Supplementary Figure S1). We sug-
gest that, in the plant clade, the RRM2 coding sequence has
been repositioned after the RRM3/RRM4-coding block
at the primary sequence level. Such domain reorganiza-
tion is not unusual in eukaryotic multidomain proteins,
and may be due to the development of an alternative splic-
ing mechanism (34,35). We used the Consurf server to
map the sequence conservation onto the atomic surface
of SHARP–RRM (36). This analysis clearly identified the
RRM3/RRM4 interface as containing multiple residues
highly conserved across eukaryotic species, with the plant
proteins being the least conserved (Figure 2A, B and C;
Supplementary Figure S2). This interface relies on amino
acids from RRM3 and RRM4 domains and in particular
residues R438, Q482, W520, and D585 (Figure 2D). Other
residues connecting RRM2 to RRM3, RRM3 to RRM4
and to theC-terminal-helix followingRRM4 are also part
of the interface (Figure 2D). Furthermore, the particular
orientation observed between RRM3 and RRM4 appears
to be unique when compared with other protein structures
containing multiple RRMs (Supplementary Figure S3).
Clearly, the respective orientation of RRM3 and RRM4
as well as the complex surface of interaction observed in
our atomic model has not been reported before. Therefore,
the presently described architecture of RRM3/RRM4 doc-
uments a new mode of interaction between RRMs.
Figure 2. RRM3–RRM4 interface conservation. (A) RRM3 and RRM4
(shown as cartoon and coloured in orange and red, respectively) are in
close contact. Bottom part shows the same protein fragment using a sur-
face representation coloured according to surface conservation (cyan: low
conservation and magenta: high conservation). (B) and (C) The RRM3–
RRM4 interface is facing the reader, and the protein surface is coloured as
in panel A. (D)Magnified view of theRRM3–RRM4 interface of SHARP:
residues located at the interface are shown as sticks and coloured according
to atom types (carbon: slate or cyan; nitrogen: blue; and oxygen: red).
To further validate the proposed modular organization
of the SHARP N-terminal region consisting of the RRM2
loosely attached to the RRM3/RRM4 unit, we performed
small angle X-ray scattering (SAXS) experiments on the
SHARP–RRM fragments R2–3–4h and R3–4h (Supple-
mentary Figure S4). The SAXS data are quite well fitted
using either the atomic models presently obtained or using
ab initio procedure (Supplementary Figure S4A). Docking
the atomic structures corresponding to RRM2 and R3–4h
fragments connected by a flexible linker into the envelope
calculated with the R2–3–4h data is possible with a slight
reorientation of RRM2 as expected from its loose attach-
ment with the RRM3/RRM4 unit (Supplementary Figure
S4B). The R3–4h fragment of the structure can be fitted
into both envelopes without any changes, strongly suggest-
ing that RRM3 andRRM4 domains form a stable unit even
in the absence of RRM2 (Supplementary Figure S4B and
C). We further suggest that this structural design likely re-
flects its importance for the SPEN protein function, most
probably by governing their atypical RNA-binding proper-
ties (see below).
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Identification of the RNA-binding properties of the SHARP–
RRM
Using gel shift assays, we then investigated how the
SHARP–RRM fragment could recognize nucleic acids.
Typically, three aromatic side chains located on -strands
1 and 3 are essential for RNA binding in canonical RRMs
(for a review, see 17,37). In the SHARP protein, RRM2
(partially), RRM3 and RRM4 exhibit aromatic residues at
the standard positions within their folded domains (Fig-
ure 3). However, the C-terminal helix of RRM4 is covering
these conserved residues through multiple hydrophobic in-
teractions (Figure 2D). The strong association of the-helix
with the -sheet in RRM4 likely prevent RNA association
at this location (Figures 2D and 3C). Moreover, the elec-
trostatic surface potential of the SHARP–RRM fragment
clearly indicate the existence of positively charged regions
near the -sheet of RRM3 as well as in the loop connect-
ingRRM3 toRRM4 and inRRM4 (Supplementary Figure
S5). To further understand howSHARP–RRMcould inter-
act withRNA,wemeasuredRNAassociationwithmultiple
SHARP constructs.
SHARP has two reported nucleic acid targets, the OC
promoter region and the H12–H13 substructure found in
the long non-coding SRA RNA (5,13,15). The later is an
85 nucleotide-long RNA element highly conserved which
adopts a stable secondary structure (38). Based on our
atomic model, we designed different protein mutants or
truncations and tested their ability to bind to the H12–H13
RNA fragment (Figure 4). We were able to confirm that our
crystallized construct was binding to the SRA RNA H12–
H13 sequence with an apparent affinity constant in the low
micromolar range (Kd, app = 1.75M;Figure 4A and B). As
the threeRRMs can potentially bind nucleic acidmolecules,
we subsequently tested several constructions correspond-
ing to different combinations of RRMs. We started with
the construct R3–4h, where the RRM2 was deleted while
keeping the RRM3–RRM4 block and the C-terminal he-
lices intact (Figure 4C). This construct is able to recog-
nize the H12–H13 RNA fragment with a similar affinity,
clearly indicating the RRM2 is not essential for the stable
recognition of the SRA RNA (Figure 4C). We then mu-
tated several residues of the RRM3 predicted to be impor-
tant for RNA binding: (i) three aromatic residues found in
the RNP1 and RNP2 motives (F441, Y478, and F480). (ii)
Two lysine residues found in the 2–3 loop and in the
linker between RRM3 and RRM4 (K470 and K512, re-
spectively). We verified that the construct with the RRM3
domain mutated (R3mut) was still stable and folded by gel
filtration chromatography and circular dichroism (Supple-
mentary Figures S6 and S7). Both measurements strongly
suggested that the mutant is well folded (Supplementary
Figures S6 and S7). Though folded, the R3mut construct
was unable to form a stable complex with the H12–H13
RNA fragment, indicating that the mutated residues within
RRM3 are important for RNA association (Figure 2D).
We then tested RRM4 and the C-terminal helices. Unfortu-
nately, the deletion of the C-terminal helices makes the pro-
tein fragment highly insoluble (data not shown). We thus
decided to delete the entire region containing the RRM4
and the helices (R2–3 construct), which resulted in a sta-
ble and folded polypeptide (Supplementary Figures S6 and
S7). We further expressed RRM3 alone and showed that it
also behaved as a stable folded domain (Supplementary Fig-
ures S6 and S7). EMSA experiments with the R2–3 protein
revealed that the RNA-binding capacity of this construct
was impaired, indicating that the RRM4 domain and the
helices also play a crucial role in RNA association (Figure
4E). Then, we tested if RRM4 could bind the RNA on its
own by mutating the canonical residues for RNA binding
in both RRM2 and RRM3 (R2mutR3mut construct, mu-
tated residues are listed in the Materials and Methods sec-
tion). TheRNAassociation was strongly reduced to a back-
ground level, indicating that RRM4 and the C-terminal he-
lices cannot bind stably the RNA on their own (Figure 4F).
As we show above, RRM3 is tightly associated with
RRM4 in our crystal structure and this association appears
conserved within the SPEN family. These RNA-binding ex-
periments strongly suggest that the RNA-binding proper-
ties of SHARP are mostly due to the newly characterized
RRM3/RRM4 block (Figures 2B and 4C). Although the
exact role of each RRM is not yet fully apprehended, we
propose that there is a strong cooperative effect between
the two RRMs based on our atomic structure and on the
RNA-binding experiments. The precise positioning of the
twoRRMs in space through their specific surface of interac-
tion leads to high affinity binding properties, as previously
observed for other multi-RRM-containing protein, such as
PTB (39,40).
The RNA structural context is important for SHARP–
RRM/SRA interaction
To further understand the RNA-binding capacities of
SHARP, we investigated the RNA sequence driving the as-
sociation, i.e. the 85 nucleotide-long H12–H13 fragment of
SRA. We measured the ability of different SRA RNA frag-
ments to displace the preformed R2–3–4h/H12–H13 com-
plex (Figure 5A). We first tested the full-length H12–H13,
which competed very efficiently, while a single-stranded
A15 oligomer did not displace the preformed SHARP–
RRM/SRA RNA complex (Figure 5B, lanes 5–7 and 8–
10). Most RRM domains have been shown to bind to short
unstructured ssRNAs (41,42). The CISBP-RNA server
was used to predict the best RNA-binding motif for the
RRM3 (43). The best RNA-binding sequence predicted
is GUGUG, and the second best predicted sequence is
ACACA. Based on these two predictions, an RNA se-
quence with an alternative purine-pyrimidine sequence is
likely to bind to RRM3. Such a consensus sequence is
partially found in the LA loop. We tested three individ-
ual loop regions of H12–H13, i.e. LA, LB, and LC region,
which did not displace the preformed complex even when
added in 100-fold molar excess (Figure 5B, lanes 11–19).
This indicates that the SHARP association with RNA is
unlikely to be driven by non-specific interaction mediated
by charged residues, as observed with proteins bound non-
specifically to RNA (44,45). These experiments with indi-
vidual loops also suggested that the RNA sequence respon-
sible for the stable and specific association with SHARP–
RRMs is not be restricted to single-stranded regions. We
then split the H12–H13 RNA into two parts, namely H12
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Figure 3. Individual RRM structures and the consensus amino acids for RNA binding. (A), (B), and (C) RRM2, RRM3, and RRM4 are shown as a
cartoon and coloured in yellow, orange, and red, respectively. Amino acids at the canonical position for RNA interaction are shown as sticks and coloured
as in Figure 1.
and H13, and performed similar experiments in an attempt
to narrow down our search for the specific determinant be-
hind SHARP/RNA recognition (Figure 5C). Both the H12
and the H13 RNA fragments were able to displace the pre-
formed complex, although they required larger molar ex-
cess than the full H12–H13 fragment (Figure 5C, lanes 7–
10 and 11–14). This result indicated that the LA but also
the LB or LC sequences, when embedded in stem-loop
structures, were efficiently binding to SHARP. In order to
test for the possibility that the specific SHARP/RNA in-
teractions were due to a folded H12–H13 RNA, we per-
formed competition experiments using three unrelated se-
quences with diverse primary and secondary structures. We
chose another fragment of SRA (H7) as a further exam-
ple of RNA with multiple predicted stem-loop secondary
structures (38). We used a 17 nt ssRNA sequence (UL),
which has multiple purine-pyrimidine dinucleotides. The
third RNA corresponded to the same UL sequence plus
a short, well-characterized stem loop (USL). We observed
that the H7 and USL fragments competed with the pre-
formed protein/RNA complex, while the ssRNA sequence
UL did not compete for the R2–3–4h association (Figure
5D). This experiment clearly indicated that secondary struc-
tures within the RNA are necessary for SHARP/RNA in-
teraction. Notably, the H7 and the USL sequences needed
to be added in larger molar excess than the H12–H13 frag-
ment to achieve the same competitive effect, indicating that
SHARP–RRM/H12–H13 association is specific (compare
lanes 5, 9, and 17 in Figure 5D). Examined together, these
experiments point towards a complex mode of association
between SHARP–RRMs and the H12–H13 fragment: a
mode which is not limited to an association mediated by
a 3–4 nucleotide single-stranded sequence likely located in
the loop LA and the -sheet surface of RRM3. The H12–
H13 secondary structure was recently shown to be identical
both in isolation and within the full-length SRARNA (46).
It seems therefore unlikely that SHARP–RRM recognizes
a particular tertiary fold adopted by the H12–H13 frag-
ment. We also tested the competing capacities of the single-
stranded and duplex DNA sequences found in the OC pro-
moter region, previously identified as a specific binding site
for the SHARP protein (5). Even though SHARP is able
to bind to the OC promoter ssDNA or duplex DNA (Sup-
plementary Figure S8), none of the DNA sequences dis-
placed the preformed protein–RNA complex in our compe-
tition assays (Supplementary Figure S8). This further vali-
dates the binding specificity of SHARP–RRMs for the SRA
RNA H12–H13 element. In an ultimate effort to identify
the contact points between SHARP and the SRA RNA,
we decided to crosslink the H12–H13 SRA RNA to the
R3–4h protein construct. After UV irradiation of the com-
plex, we isolated and primer extended the crosslinked RNA
(Supplementary Figure S9). Several weak crosslinks were
observed in the single-stranded regions of the H12–H13
RNA (Supplementary Figure S9) reinforcing the idea that
SHARP has multiple contact points within the RNA. The
major crosslinking events happened at the dinucleotides
UG of the loop LA (positions 36–37 and 39–40 of the H12–
H13 element; Supplementary Figure S9), which corrobo-
rate the predicted binding site for theRRM3, i.e. alternating
pyrimidine/purine sequence.
DISCUSSION
The SHARP protein is an important regulator of various
transcriptional processes such as nuclear receptor-mediated
responses, Notch-mediated transcriptional activation, or
osteoblast differentiation (5,12,13). SHARP belongs to a
protein family characterized by a SPOC domain at the C-
terminus, and at least three RBDs at the N-terminus (Fig-
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Figure 4. Identification of the protein region responsible for the SRA RNA association. (A) Representative EMSA used to quantify R2–3–4h construct
association with the SRA RNA fragment H12–H13. (B) Quantification of the EMSA experiment shown in panel A. The bound fraction was quantified
and analysed using the Hill Equation, and the fit is shown as a solid line. The calculated dissociation constant (Kd , app) and the quality of the fit are
indicated. (C) EMSA autoradiogram obtained when measuring the RNA-binding capacity of the R3-R4h construct. (D) EMSA autoradiogram showing
the very weak RNA-binding activity of the R3mut construct. (E) EMSA autoradiogram showing the poor RNA-binding activity of the R2–3 construct.
(F) EMSA autoradiogram obtained using the R2mutR3mut construct and indicating that the RRM4 plus the two helices participate only marginally in
RNA association.
ure 3A). It is a large multidomain protein of ∼400 kDa,
which renders its structural characterization very difficult.
We have solved the structure of the N-terminal protein frag-
ment containing three RRM domains, enhancing our un-
derstanding of proteins containing RRM that are associ-
ated with negative transcriptional regulation (47–49).
With the increasing amount of structural information
on multidomain proteins, it has become clear that pro-
teins with multiple RRMs generally adopt unique architec-
tures; this helps them achieve higher binding affinity and
specificity for their RNA targets (50). One central ques-
tion associated with such proteins is the functional rele-
vance of these interdomain contacts. We identified an unex-
pected and stable interaction between RRM3 and RRM4.
The surface of interaction found between these two pro-
tein subdomains is highly conserved throughout evolution.
The RRM3 and RRM4 domain association is stable as ob-
served by SAXS measurement (Supplementary Figure S4).
Furthermore, we show that both RRMs are needed in or-
der to achieve a stable RNA association (Figure 4C–F).
The RRM3 domain contains the canonical residues allow-
ing this domain to bind RNA. However, the association
of the SHARP–RRM fragment is not limited to the short
single-stranded RNA-binding region present in the RRM3
as none of the single-stranded loops present in the H12–
H13 sequence can compete efficiently with the binding of
the full-length RNA fragment. We revealed that the pres-
ence of double-stranded RNA sequences is important to
displace the preformed complex between SHARP–RRM
and the SRA RNA. The -sheet surface of RRM4 strongly
interacts with an -helix a situation reminiscent to the one
encountered in various other RRMs, some of them shown
to bind a double-stranded region within their RNA tar-
gets (19). We propose that the RRM3/RRM4 unit con-
tributes to the overall RNA-binding affinity of SHARP,
with a preference for alternating UG sequence located in
structured loop (stem loop). We also show that SHARP
affinity is higher for ribonucleotide sequences as ssDNA or
duplex DNA sequences previously shown to interact with
SHARP in vitro (5) were not able to compete efficiently for
the binding (Supplementary Figure S8). Our structural and
biochemical studies unravelled a new architecture for a pro-
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Figure 5. SHARP–RRM association with RNA relies on stem-loop structure. (A) Secondary structures and sequences of the RNA molecules used for
the competition assays reported in panels B, C, and D. The structural architecture of the H12–H13 fragment is based on that established by Novikova et
al. (38). The loop regions and the single-strand RNA are coloured in blue (LA), yellow (LB), red (LC), and green (UL). (B) RNA-binding competition
assays to determine the loop sequences mediating association between SHARP–RRM (R2–3–4h construct) and the SRA RNAH12–H13. Free RNA and
R2–3–4h complex are shown in lanes 1 and 2. Competition assays were performed with the following RNAs: loop LA (lanes 11–13), loop LB (lanes 14–16),
and loop LC (lanes 17–19). (C) Similar competition experiments performed with individual substructures H12 and H13 from the SRARNA. Competition
assays were performed with H12 RNA (lanes 7–10) and H13 RNA (lanes 11–14). (D) Competition experiments performed with various unrelated RNAs
showing the importance of a stem region for the competitive capacity of the RNA. Competition assays were performed with cold H7 RNA (lanes 7–10),
unrelated loopRNA (UL, lanes 11–14), and unrelated stem-loopRNA (USL, lanes 15–18). Concentrations of the coldRNAswere added inmolar excess as
indicated in each panel. Positive and negative controls for efficient competitions are identical in panels B, C, and D (labelled H12–H13 or A15, respectively).
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tein containing multi-RRM, increasing the already broad
repertoire of nucleic acid recognition modes of these do-
mains and underlined the preference of this protein for UG-
containing structured stem loops.
Although the exact function of the SHARPprotein is still
the subject of intense research, we would like to speculate
that the key to understanding its various reported interact-
ing partners lies in the highly atypical nucleic acid bind-
ing properties presently observed (51,52). SHARP is a pro-
tein scaffold that is found in various transcriptional reg-
ulatory complexes acting around the polymerase holoen-
zyme. Moreover, long ncRNAs have been proposed to
mimic an open promoter structure to regulate polymerase
II-mediated transcription (53). We propose that the SRA
RNA may mimic an active transcription unit, which would
explain its capacity to recruit SHARP and possibly could
help understand the many functions attributed to this long
ncRNA.
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